New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Intuitive Surgical, Inc.

ISRG

Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.

Revenue
+21.7%
EPS
−23.6%
Free cash flow
+51.0%

Quarter to September 2026, against a year earlier

399.33 7.91 −1.94%

After hours trading: 400.00, up 0.17%, last trade 4:23pm Eastern.

Market cap
$141.2B
P/E
47.8×
Fwd P/E FY26e
51.3×
Dividend yield
—
F-score
7/9
ROIC
17.0%
Net debt / EBITDA
−1.6×
Payout ratio
—

Revenue to profit Twelve months to Sep 30, 2026

Of every $100 of revenue, $25.68 was left as profit. Gross margin has risen three quarters running, from 66.0% to 67.2%. What is an income statement?

Revenue to profit, in billions of dollars and as a share of revenue
Revenue11.6100.0%
Cost of revenue−3.8−32.8%
Gross profit7.867.2%
Research & development−1.5−12.9%
Selling, general & admin−2.6−22.0%
Other operating costs−0.5−3.9%
Operating income3.328.4%
Other income, net+0.32.9%
Income tax−0.6−5.6%
Net income3.025.7%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue$10.1B$10.6B$11.0B$11.6B
Operating income$2.9B$3.2B$3.5B$3.3B
Net income$2.9B$3.0B$3.2B$3.0B
Net margin (right axis)28.6%28.3%28.6%25.7%
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Revenue

+8 more TTM periods

10,064.70 10,582.10 11,034.40 11,578.00
Gross Profit
6,642.30 7,015.10 7,357.60 7,779.50
Operating Income
2,945.50 3,222.70 3,451.20 3,284.10
EBT
3,311.40 3,583.30 3,805.80 3,619.00
Income after Tax
2,876.60 2,998.90 3,157.90 2,973.10
Net Income Common
2,856.00 2,979.10 3,138.80 2,957.20
EPS (Diluted)
7.89 8.25 8.73 8.27
Shares (Diluted, Weighted)
363.30 362.10 360.40 357.85
Gross Margin
66.00% 66.29% 66.68% 67.19%
EBIT Margin
29.27% 30.45% 31.28% 28.37%
Net Profit Margin
28.38% 28.15% 28.45% 25.54%
Free Cash Flow Margin
24.75% 27.22% 29.62% 31.47%
EBITDA
3,622.60 3,957.70 4,253.80 4,135.80
EBIT
2,945.50 3,222.70 3,451.20 3,284.10

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 2, 2026